This test is most useful if any of these apply to you.
Many adults carry the cold sore virus, and most of the time it hides in the nerves of the face doing nothing. Every so often it wakes up and sends copies of itself into your mouth, often with no sore, no tingle, and no sign at all. This test tells you whether that was happening on the day you collected your sample.
The virus is HSV-1, herpes simplex virus type 1, and the test looks for its DNA in your saliva. A positive result is common in healthy people and rarely means you're sick. It's most useful for confirming what's behind a flare, learning how often you shed, and spotting reactivation that travels with a few specific conditions.
The lab uses PCR, short for polymerase chain reaction. PCR copies a short stretch of the virus's genetic code over and over until there's enough to see. Research and clinical PCR assays can detect very small amounts of viral DNA, sometimes down to only a few copies in the reaction.
That sensitivity is why PCR is preferred for many herpes diagnoses. In mucosal samples, PCR found the virus about four times as often as growing it in a lab dish, 12.1% vs 3.0% of samples. Across other clinical specimens, PCR raised detection by about 30% over older standard lab methods.
Most assays read a stretch of genetic code that differs between the two herpes simplex types, so the result is specific to type 1. One widely used version told type 1 and type 2 apart correctly more than 99.5% of the time. That matters because the old split, type 1 above the waist and type 2 below, no longer holds: in one large set of skin and mucous-membrane samples, type 1 caused 40% of genital infections.
What PCR finds is viral DNA, which isn't the same as proof of live, infectious virus. The two are related, though. In mucosal samples, the more copies of viral DNA present, the more likely the virus would also grow in a lab dish.
The established use is PCR on fresh lesions, spinal fluid, or other clinically chosen samples. The newer use is saliva tracking in otherwise healthy people. There are no universal saliva cutoffs that turn this into a normal-or-abnormal score.
The useful thing to know before you test is how often healthy people come back positive. The virus doesn't need a cold sore to reach your saliva, and it keeps its own schedule. Oral shedding happens independently of cold sore flares, so a positive result doesn't forecast your next outbreak.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 50 normal adults, sampled every day for a month | How many had HSV-1 DNA in tears or saliva at least once | 49 out of 50 did, and 37.5% of mouth samples were positive |
| 1,000 oral surgery outpatients, sampled once | How often a single saliva sample was positive | 4.7% were positive by PCR |
| 8 adults with recurrent cold sores, swabbed repeatedly for about 5 weeks | Whether positive shedding days came with or without a sore | 94.2% of positive days had no visible sore |
Sources: Kaufman et al.; Tateishi et al.; Ramchandani et al.
A single sample catches one moment. In daily-sampling studies, many people who carry the virus shed at least once, yet on any given day most samples can still be negative. So one positive doesn't mean you're sick, and one negative doesn't mean you're virus-free.
It also means a positive or more frequent result isn't worse the way a high cholesterol reading is. This is an activity marker. It tells you the virus was awake. What that means depends on context: silent shedding in a healthy person is ordinary, while the same finding alongside sudden facial weakness or a flare of mouth blisters carries more weight.
Silent shedding is one way the virus spreads, and it's why so many people carry it. A pooled analysis of US studies estimated that about 63.5% of general-population adults had evidence of prior HSV-1 infection. National survey data covering ages 14 to 49 put the figure lower, around 48% in 2015 to 2016, and rates have been falling over time. Some communities report much higher rates. Researchers who tracked daily shedding in healthy adults pointed to frequent, symptom-free oral shedding as a likely route of passing the virus to partners.
If you get cold sores, saliva can turn positive before or around the visible sore, but timing varies. In 30 adults with frequent recurrent cold sores, HSV-1 was detectable in 87% during one followed recurrence, and shedding occurred both before and after the visible lesion.
The amount of virus rises fast and falls fast. In lesion samples from recurrent cold sores, viral DNA peaked about 48 hours after symptoms started and was not detected beyond 96 hours. Oral shedding episodes can be brief, but not always: one detailed oral-mucosa study found a median episode length of 3.25 days, with a range from 1 to 12 days.
Sample early if you're trying to catch a flare. A fresh swab of the sore itself is the most direct test. Saliva is the backup when there's nothing visible to swab yet.
Bell's palsy is sudden weakness on one side of the face from dysfunction of the facial nerve. Reactivation of this virus has been proposed as one driver in some cases, but its role is unproven. In one older study, half of people with Bell's palsy had viral DNA in saliva, compared with about one in five healthy HSV-seropositive volunteers. Later studies found much lower detection rates, and at least one found no meaningful difference from healthy controls.
Liquid oral fluid collection gave better detection than absorbent cotton rolls in people with acute facial palsy. Researchers have proposed oral-fluid testing as one piece of information that may help treatment decisions, but it does not settle whether antivirals will help.
New facial weakness needs same-day medical care, because a stroke can look similar. A saliva result is something to bring to that visit, not a reason to wait.
After a burst brain aneurysm, the brain's arteries can clamp down days later and cause a second injury. Doctors call the bleed a subarachnoid hemorrhage and the clamping vasospasm. In 36 people recovering from this kind of bleed, those with more viral DNA in saliva had worse spasm, and saliva viral load accounted for 27.8% of the differences in spasm severity between patients.
This is a small intensive-care study, not a finding about healthy people. It fits a pattern of the virus waking up when the body is under severe strain. A similar pattern has been reported in critically ill COVID-19 patients, where detected reactivation in respiratory or other clinical samples went along with higher 60-day death rates and more hospital-acquired pneumonia.
Pemphigus vulgaris is an autoimmune disease that blisters the skin and the lining of the mouth. In a small group of people with early pemphigus vulgaris affecting the mouth, high amounts of viral DNA showed up in saliva in 6 of 16 people, or 37.5%. Detection was usually brief and early. The study does not prove the virus caused the disease.
Viral DNA also turns up in the saliva of some people with Behcet's disease, though its link to their ulcers is unclear. In one older study, saliva was positive in 39.4% of people with Behcet's disease and 13.8% of healthy controls, but detection did not line up with having an oral ulcer at that visit. If you get mouth sores that don't behave like ordinary cold sores, a positive result is one clue among several, not an answer.
Shedding can run more often when the immune system is under pressure. In 22 people living with HIV followed with daily oral swabs, HSV-1 appeared on 14.3% of days. In another study of 30 asymptomatic people with HIV sampled once, saliva was positive in 6.67%. Sampling frequency changes what you see.
Saliva from people with HIV also carried multiple herpes viruses more often than saliva from people without it. People with cancer face a higher risk of complications from herpes simplex and shingles viruses, so reactivation matters more for them than for healthy adults.
The headlines tying this virus to dementia come from studies of infection history, mostly antibody tests and medical records, not viral DNA in saliva. In 1,002 older adults followed forward in time, herpes simplex infection was linked to roughly double the risk of dementia.
The picture isn't consistent. In a population study of 1,915 people, HSV-1 antibody status was tied to faster cognitive decline but not to dementia itself, and a pooled review judged the evidence across studies inconsistent and low in quality. In a Swedish registry study of 265,172 people, those treated with antiviral drugs for clear herpesvirus infection had lower long-term dementia risk.
None of these studies measured viral DNA in saliva, so a positive result on this test says nothing direct about your dementia risk. The same caution applies to gum disease. A pooled analysis linked HSV-1 found in the film of bacteria below the gumline to periodontitis, but that's a different sample from saliva.
The antibody blood test answers a different question. It looks for the long-lasting antibodies your immune system makes after infection, labeled HSV-1 IgG on most reports, so it tells you whether you've ever been infected. Saliva PCR tells you whether the virus was active in your mouth on one day.
Each misses things the other catches. Antibodies take weeks to appear after a new infection: a median of 25 days by one common method and 33 days by the reference method, in people with newly acquired genital herpes. In one evaluation, automated antibody tests caught fewer than 85% of true HSV-1 infections. Type-specific antibody tests came back falsely negative in 12% to 30% of people whose recurrent genital herpes had been confirmed by DNA testing.
No vaccine for herpes simplex virus is approved. A positive antibody test reflects infection, not vaccination.
Because shedding comes and goes, the number that describes you isn't a single result but a rate: how often the virus shows up across repeated samples. One reading tells you about one day. Several readings tell you how active the virus is in your mouth.
Using saliva to track a healthy person is a newer application without standard cutoffs, so your own pattern is the comparison that means something. If the lab reports an amount rather than just detected or not detected, stay with the same lab and the same collection method so the numbers line up.
Read the result against what's happening in your body, then act on the pattern.
Evidence-backed interventions that affect your HSV Type 1 DNA level
HSV Type 1 DNA is best interpreted alongside these tests.
HSV Type 1 DNA is included in these pre-built panels.